Patients are our inspiration for coming to work every day and pursuing innovations that can have a profound impact on their lives. Our commitment to life, and to patients, extends from bench to bedside, and around the globe. Within North America, we make a concerted effort to address the needs of patients through access and assistance programs, research, and meaningful collaborations with patient communities.
Access to treatment
Kyowa Kirin Cares offers access and reimbursement assistance as well as personal and comprehensive support for patients and caregivers, at the beginning and during the course of treatment.
Kyowa Kirin’s Policy for Requests for Expanded Access to Unapproved Drugs describes the principles and procedures that the company will follow when considering requests by physicians for use of unapproved Kyowa Kirin drugs outside of clinical trials.
Engaged in patient
Whether fighting a rare disease or managing a daily battle with symptoms, many patients and their families turn to advocacy organizations as a source for unbiased education, advice, and treatment support. Kyowa Kirin North America is proud to engage with foundations that provide these services in areas aligned with our portfolio.
We work with patients and community leaders in a number of ways:
- Conducting research into patient and caregiver needs
- Improving the design of clinical trials and marketing programs
- Investing in disease awareness and education campaigns
- Advancing patient-friendly policies for affordable coverage and care
- Supporting meetings and educational events in our therapeutic areas
Advocacy organizations who are interested in meeting with Kyowa Kirin North America to discuss opportunities for collaboration may reach out to Public Affairs email@example.com or submit grant requests for consideration at firstname.lastname@example.org